Filing Details
- Accession Number:
- 0001144204-10-036801
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-07-06 13:00:00
- Reporting Period:
- 2010-07-01
- Filing Date:
- 2010-07-06
- Accepted Time:
- 2010-07-06 19:18:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 908259 | Oxigene Inc | OXGN | Biological Products, (No Disgnostic Substances) (2836) | 133679168 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202286 | D Tamar Howson | C/O Oxigene, Inc. 701 Gateway Blvd., Ste. 210 South San Francisco CA US 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value Per Share | Acquisiton | 2010-07-01 | 25,000 | $0.39 | 50,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Ms. Howson received shares of OXiGENE, Inc. common stock ("Shares") pursuant to the OXiGENE, Inc. Amended and Restated Director Compensation Policy (the "Policy") as compensation for Board of Directors and Committee Services to be provided during the last six months of 2010. The closing price per share on June 30, 2010, the last trading day prior to the grant date for the Shares issued, was $0.3801
Billionaire Hedge Funds
